Certara Inc

NASDAQ:CERT  
25.57
-1.18 (-4.41%)
Products

Certara Announces FDA Renewal And Expansion Of Certara’s Biosimulation Software For Reviewing Regulatory Submissions

Published: 12/21/2021 13:15 GMT
Certara Inc (CERT) - Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory Submissions.
Certara Inc - FDA Has Renewed and Expanded Its User Licenses of Certara's Phoenix Software.